Helix BioMedix Inc. (OTCMKTS:HXBM – Get Free Report) was the target of a significant decrease in short interest in the month of September. As of September 15th, there was short interest totaling 87 shares, a decrease of 57.4% from the August 31st total of 204 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 901 shares, the days-to-cover ratio is presently 0.1 days.
Helix BioMedix Stock Down 11.9%
Helix BioMedix stock traded down $0.60 during trading hours on Monday, hitting $4.40. 100 shares of the company traded hands, compared to its average volume of 436. The firm’s 50-day simple moving average is $3.10 and its two-hundred day simple moving average is $2.05. Helix BioMedix has a 1-year low of $1.00 and a 1-year high of $6.50.
Helix BioMedix Company Profile
Helix BioMedix, Inc is a biotechnology company focused on the discovery, development and commercialization of bioactive peptides for personal-care, cosmetic and related life-science applications. Its work centers on peptides designed to support skin health and appearance, including products used in anti-aging, skin-repair and antimicrobial formulations.
The company develops proprietary peptide ingredients and licenses or supplies them to manufacturers and formulators for use in skincare and other topical products.
Read More
- Five stocks we like better than Helix BioMedix
- 3 Dividend Stocks Investors May Be Missing in 2026
- 3 Healthcare Stocks Showing Why the Sector Still Has Momentum
- Akamai’s Anthropic Deal Puts $5.5 Billion Behind Its Edge AI Pivot
- 3 Stocks Under the Microscope After Large Insider Sales
Receive News & Ratings for Helix BioMedix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioMedix and related companies with MarketBeat.com's FREE daily email newsletter.
